[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] GERSTUNG M,JOLLY C,LESHCHINER I,et al. The evolutionary history of 2,658 cancers[J].Nature,2020,578(7793):122-128.
[3] LIU X,HU Y,HAO C,et al.PIKE-A is a proto-oncogene promoting cell growth,transformation and invasion[J].Oncogene,2007,26(34):4918-4927.
[4] SHANG B,GAO A,PAN Y,et al.CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis[J].Cell Death Disease,2014,5(6):e1285.
[5] BRADLEY G,ODELL E W,RAPHAEL S,et al.Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma[J].Br J Cancer,2010,103(9):1432-1442.
[6] DUNN J M,MACKENZIE G D,OUKRIF D,et al.Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy[J].Br J Cancer,2010,102(11):1608-1617.
[7] ZHAO L,WEI W Q,ZHAO D L,et al.Population-based study of DNA image cytometry as screening method for esophageal cancer[J].World J Gastroenterol,2012,18(4):375-382.
[8] KATZKA D A,SMYRK T C,ALEXANDER J A,et al.Accuracy and safety of the cytosponge for assessing histologic activity in eosinophilic esophagitis:a two-center study[J].Am J Gastroenterol,2017,112(10):1538-1544.
[9] HAISLEY K R,DOLAN J P,OLSON S B,et al.Sponge sampling with fluorescent in situ hybridization as a screening tool for the early detection of esophageal cancer[J].J Gastrointest Surg,2017,21(2):215-221.
[10] YOUSEF F,CARDWELL C,CANTWELL M M,et al.The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus:a systematic review and meta-analysis[J].Am J Epidemiol,2008,168(3):237-249.
[11] REID B J,LEVINE D S,LONGTON G,et al.Predictors of progression to cancer in Barrett's esophagus:baseline histology and flow cytometry identify low- and high-risk patient subsets[J].Am J Gastroenterol,2000,95(7):1669-1676.
[12] McMANUS D T,OLARU A,MELTZER S J.Biomarkers of esophageal adenocarcinoma and Barrett's esophagus[J].Cancer Res,2004,64(5):1561-1569.
[13] MONTGOMERY E,GOLDBLUM J R,GREENSON J K,et al.Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus:a follow-up study based on 138 cases from a diagnostic variability study[J].Hum Pathol,2001,32(4):379-388.
[14] FRITCHER E G,BRANKLEY S M,KIPP B R,et al.A comparison of conventional cytology,DNA ploidy analysis,and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus[J].Hum Pathol,2008,39(8):1128-1135.
[15] BIRD-LIEBERMAN E L,DUNN J M,COLEMAN H G,et al.Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus[J].Gastroenterology,2012,143(4):927-935.e3.
[16] SIKKEMA M,KERKHOF M,STEYERBERG E W,et al.Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus:a case-control study[J].Am J Gastroenterol,2009,104(11):2673-2680.
[17] FENG X S,YANG Y T,GAO S G,et al.Prevalence and age,gender and geographical area distribution of esophageal squamous cell carcinomas in North China from 1985 to 2006[J].Asian Pac J Cancer Prev,2014,15(5):1981-1987.
[18] KILLCOYNE S,GREGSON E,WEDGE D C,et al.Genomic copy number predicts esophageal cancer years before transformation[J].Nat Med,2020,26(11):1726-1732.
[19] ZUO L F,LIN P Z,QI F Y,et al.Flow cytometric analysis of DNA,telomerase content and multi-gene expression in esophageal epithelial dysplasia[J].World J Gastroenterol,2003,9(11):2409-2412.
[20] 王兴武,国前,魏玲,等.DNA含量和S期细胞比值与食管癌生物学特性的关系[J].中华肿瘤防治杂志,2001,8(4):362-364.
[21] MUNCK-WIKLAND E,AUER G,KUYLENSTIERNA R,et al.Image cytometry DNA analysis of invasive squamous cell carcinoma of the esophagus[J].Anticancer Res,1989,9(3):545-549.
[22] TSUTSUI S,KUWANO H,MORI M,et al.A flow cytometric analysis of DNA content in primary and metastatic lesions of esophageal squamous cell carcinoma[J].Cancer,1992,70(11):2586-2591.
[23] 李进东,王文光,许金良,等.食管鳞状细胞癌DNA含量和倍体分析的临床意义[J].临床肿瘤学杂志,2007,12(12):3.
[24] 左连富,林培中,齐凤英,等.食管癌前细胞DNA含量及多基因表达的定量检测[J].中华肿瘤杂志,2002, 24(1):30-33.
[25] 原志庆,姜红光,许春雷,等.食管鳞状细胞癌DNA倍体异质性研究及其临床病理学意义[J].中华病理学杂志,1996,25(3):159-161.
[26] TSUTSUI S,KUWANO H,MORI M,et al.Comparison of cell nuclear DNA contents between intraepithelial and invasive components of oesophageal squamous cell carcinoma[J].Eur J Cancer,1991,27(5):620-624.
[27] ANDREJEVIC-BLANT S,OSTERHELD M C,CA RON L,et al.Deoxyribonucleic acid content as an indicator of progression of squamous cell carcinogenesis in the esophagus:comparative analysis on imprint-cytospin and tissue section preparation[J].Cancer Detection Prevention,2006,30(3):276-283.
[28] HUI A M,ITABASHI M,KATO H,et al.Flow cytometric DNA analysis of submucosal carcinoma of the esophagus[J].Jpn J Clin Oncol,1994,24(1):26-31.
[29] ROBASZKIEWICZ M,REID B J,VOLANT A,et al.Flow-cytometric DNA content analysis of esophageal squamous cell carcinomas[J].Gastroenterology,1991,101(6):1588-1593.
[30] BLANT S A,BALLINI J P,CARON C T,et al.Evolution of DNA ploidy during squamous cell carcinogenesis in the esophagus[J].Dis Esophagus,2001,14(3-4):178-184.
[31] ZHU S C,LI R,WANG Y X,et al.Impact of simultaneous assay,the PCNA,cyclinD1,and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system[J].World J Gastroenterol,2005,11(25):3823-3829.
[32] BÖTTGER T,STÖRKEL S,STÖCKLE M,et al.Image analysis of DNA cytometry for assessing prognosis after resection of esophageal cancer[J].Chirurg,1991,62(6):467-472,discussion 472-473.
[33] OKI E,HISAMATSU Y,ANDO K,et al.Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers[J].J Gastroenterol,2012,47(4):351-358.
[34] GLEESON C M,SLOAN J M,McMANUS D T,et al.Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia[J].Br J Cancer,1998,77(2):277-286.
[35] KIM J Y,CHO H J.DNA ploidy patterns in gastric adenocarcinoma[J].J Korean Med Sci,2000,15(2):159-166.
[36] FURUYA T,UCHIYAMA T,MURAKAMI T,et al.Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers[J].Clin Cancer Res,2000,6(7):2815-2820.
[37] ZHANG J F,ZHANG Y P,HAO F Y,et al.DNA ploidy analysis and expression of MMP-9,TIMP-2,and E-cadherin in gastric carcinoma[J].World J Gastroenterol,2005,11(36):5592-5600.
[38] IKEGUCHI M,KATANO K,OKA A,et al.Relationship between the cell-proliferative activity of gastric cancers and that of the normal epithelium[J].Anticancer Res,1995,15(3):821-825.
[39] SHEN K L,CHU C H.DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese[J].World J Surg,1994,18(3):433-439,discussion 439-440.
[40] FLYGER H L,CHRISTENSEN I J,THORUP J,et al.DNA aneuploidy in gastric carcinoma.Flow cytometric data related to survival,location,and histopathologic findings[J].Scand J Gastroenterol,1995,30(3):258-264.
[41] SASAKI O,SOEJIMA K,KORENAGA D,et al.Comparison of the intratumor DNA ploidy distribution pattern between differentiated and undifferentiated gastric carcinoma[J].Anal Quant Cytol Histol,1999,21(2):161-165.
[42] SASAKI O,SOEJIMA K,HARAGUCHI Y.Intra-tumor DNA ploidy distribution pattern and its relation to histologic type in gastric carcinoma[J].Pathol Res Pract,1992,188(4-5):545-549.
[43] ZHANG K,DUAN J Y,SONG Y G,et al.Significance of detection of DNA ploidy and T lymphocytes in patients with gastric cancer or precancerous lesions[J].World Chin J of Digestol,2016,24(9):1433.
[44] SUGAI T,HABANO W,JIAO Y F,et al.Analysis of genetic alterations associated with DNA diploidy,aneuploidy and multiploidy in gastric cancers[J].Oncology,2005,68(4-6):548-557.
[45] D'URSO V,COLLODORO A,MATTIOLI E,et al.Cytometry and DNA ploidy:clinical uses and molecular perspective in gastric and lung cancer[J].J Cell Physiol,2010,222(3):532-539.
[46] WU Y F,XU H M,CHEN J Q.Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement,venous invasion and prognosis[J].Chin Med J(Engl),2004,117(10):1530-1535.
[47] 吴云飞,陈峻青,何三光,等.胃癌细胞DNA含量、细胞增殖比率与淋巴结转移规律的研究[J].中华肿瘤杂志,1997,19(1):62-64.
[48] DANOVA M,MAZZINI G,WILSON G,et al.Ploidy and proliferative activity of human gastric carcinoma:a cytofluorometric study on fresh and on paraffin embedded material[J].Basic Appl Histochem,1987,31(1):73-82.
[49] D'AGNANO I,D'ANGELO C,SAVARESE A,et al.DNA ploidy,proliferative index,and epidermal growth factor receptor:expression and prognosis in patients with gastric cancers[J].Lab Invest,1995,72(4):432-438.
[50] OSHIRO T,BABA H,OKUYAMA T,et al.Fluorocytometric DNA analysis of intestinal metaplasia associated with gastric carcinoma[J].Gan To Kagaku Ryoho,1993,20(6):709-712.
[51] 左连富,高国栋,郭建文,等.胃癌前病变细胞DNA倍体的研究[J].中华肿瘤杂志,1991,13(3):180-183.
[52] MACARTNEY J C,CAMPLEJOHN R S.DNA flow cytometry of histological material from dysplastic lesions of human gastric mucosa[J].J Pathol,1986,150(2):113-118.
[53] 吴平平,王瑞年,金承志,等.用图象分析法测定胃肠粘膜重度异型增生与腺癌细胞.[J].上海第二医科大学学报,1991,11(2):5.
[54] SANTORO E,CARBONI M,CATARCI M,et al.DNA ploidy,proliferative index and EGF-R status in 130 cases of resected gastric cancer-a multivariate analysis[J].Hepatogastroenterology,1997,44(15):826-837.
[55] 汪必成,罗峻,熊永炎.胃腺癌Bcl-2、增殖细胞核抗原表达及DNA含量与癌浸润转移的关系[J].武汉大学学报(医学版),2005,26(3):4.
[56] ESTEBAN F,DE VEGA D S,GARCIA R,et al.DNA content by flow cytometry in gastric carcinoma:pathology,ploidy and prognosis[J].Hepatogastroenterology,1999,46(27):2039-2043.
[57] HORII A,KONISHI E,URATA Y,et al.DNA-cytofluorometric,histopathological and immunohistochemical analyses of pancreatoduodenal cancers[J].Gan To Kagaku Ryoho,1993,20(6):808-811. |
